New Delhi, Jul 21 (PTI) Drug firm Cipla Ltd on Monday said it has inked definitive agreements to invest in iCaltech Innovations.

The Mumbai-based company, however, did not share financial details.

Also Read | British Royal Navy F-35B Stealth Fighter Jet to Fly Out of India on July 22, Here’s How Much Kerala's Thiruvananthapuram Airport Earned in Parking Fees.

iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core focus on respiratory care.

Achin Gupta, Global COO, Cipla Limited, said, "As lung leaders, our decision to invest in iCaltech reflects Cipla's commitment to advancing respiratory diagnostics."

Also Read | Kolkata Fatafat Result Today, July 21, 2025: Kolkata FF Live Winning Numbers Released, Know When and Where To Check Result Chart of Satta Matka-Type Lottery Game.

To reduce the existing gap in the current ecosystem, the strategic funding will enable iCaltech to further expand and develop innovative devices, he added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)